Gilead Sciences, Inc. $GILD Stake Lowered by Miller Howard Investments Inc. NY

robot
Abstract generation in progress

Miller Howard Investments Inc. NY significantly reduced its stake in Gilead Sciences (NASDAQ:GILD) by 1.3% in the fourth quarter, now holding 654,778 shares valued at $80.37 million. This move comes amid a mix of positive news, such as regulatory approvals for its Arcellx acquisition and analyst price target increases, and negative signals, including significant insider selling by the CEO and a weaker-than-expected performance of a new HIV drug. Despite the stake reduction, analysts remain largely constructive on Gilead, with an average target price of $157.35 and a “Moderate Buy” rating.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin